VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 21 filers reported holding VASCULAR BIOGENICS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $29,000 | +3.6% | 21,400 | 0.0% | 0.03% | +17.4% |
| Q2 2019 | $28,000 | -98.1% | 21,400 | -97.6% | 0.02% | -98.2% |
| Q3 2018 | $1,489,000 | -24.5% | 896,771 | 0.0% | 1.26% | -24.9% |
| Q2 2018 | $1,973,000 | -4.4% | 896,771 | 0.0% | 1.68% | -20.8% |
| Q1 2018 | $2,063,000 | -67.6% | 896,771 | 0.0% | 2.12% | -62.3% |
| Q4 2017 | $6,367,000 | +21.3% | 896,771 | +4.2% | 5.61% | +25.0% |
| Q3 2017 | $5,250,000 | +37.1% | 860,605 | 0.0% | 4.49% | -11.6% |
| Q2 2017 | $3,830,000 | -19.1% | 860,605 | 0.0% | 5.08% | -28.9% |
| Q1 2017 | $4,733,000 | +13.4% | 860,605 | 0.0% | 7.14% | -2.6% |
| Q4 2016 | $4,174,000 | -5.3% | 860,605 | 0.0% | 7.32% | -5.2% |
| Q3 2016 | $4,406,000 | +11.1% | 860,605 | 0.0% | 7.73% | +500.8% |
| Q2 2016 | $3,967,000 | – | 860,605 | – | 1.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 1,896,902 | $4,173,000 | 5.19% |
| Knoll Capital Management, LLC | 896,771 | $1,973,000 | 1.68% |
| SABBY MANAGEMENT, LLC | 1,856,169 | $4,084,000 | 0.63% |
| 683 Capital Management, LLC | 346,574 | $762,000 | 0.05% |
| Virtu Financial LLC | 64,203 | $141,000 | 0.01% |
| Spark Investment Management LLC | 29,300 | $64,000 | 0.00% |
| Alyeska Investment Group, L.P. | 83,333 | $183,000 | 0.00% |
| Burt Wealth Advisors | 1,674 | $4,000 | 0.00% |
| A.R.T. Advisors, LLC | 24,682 | $54,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 29,220 | $64,000 | 0.00% |